Immunome Newsroom

Immunome (IMNM) Receives a Buy From J.P. Morgan

TipRanksNov 19 20:13

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Futu NewsNov 14 22:33

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsNov 14 21:33

Immunome Is Maintained at Overweight by Piper Sandler

Dow JonesNov 14 20:36

Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $21

Futu NewsNov 14 20:31

Immunome Analyst Ratings

BenzingaNov 14 20:27

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsNov 14 09:32

Promising Growth Potential for Immunome: Buy Rating Backed by Strategic Acquisitions and Innovative Pipeline

TipRanksNov 14 09:17

Immunome Initiated at Overweight by Stephens & Co.

Dow JonesNov 8 20:17

Stephens Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $30

Futu NewsNov 8 06:32

Immunome Analyst Ratings

BenzingaOct 25 23:07

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Futu NewsOct 25 20:31

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsSep 16 20:31

TD Cowen Sticks to Its Buy Rating for Immunome (IMNM)

TipRanksSep 16 19:49

Wedbush Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33

Futu NewsAug 14 20:34

Leerink Partners Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $38

Futu NewsAug 13 22:32

Buy Rating Affirmed on Immunome: Promising Clinical Trials and Strategic Growth Prospects

TipRanksAug 13 22:23

Wedbush Reiterates Outperform on Immunome, Maintains $33 Price Target

BenzingaAug 13 21:07

Immunome Price Target Cut to $23.00/Share From $27.00 by Piper Sandler

Dow JonesAug 13 19:36

TD Cowen Maintains Immunome(IMNM.US) With Buy Rating

Futu NewsAug 13 19:31